Loading
Journal of AIDS and HIV Treatment
ISSN: 2688-7436
Latest Articles
Plasma Levels of Secretory Calreticulin among HIV Infected Patients in Bauchi State
Ahmed Musab , Ibrahim Yazid Gobir , LAWAL ROGO , Auwal Idris Kabuga , Yahaya Zakari
Human immunodeficiency virus (HIV) is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome. The objective was to evaluate plasma levels of Calreticulin (CALR) in HIV positive and negative individuals.
J AIDS HIV Treat, 2023, Volume 5, Issue 1, p1-8 | DOI: 10.33696/AIDS.5.040
Mental Health and Cognitive Care for Successful Aging with HIV
Paroma Mitra
Globally, an estimated 4.2 million people above the age of 50 now have diagnosis of HIV (Human Immunodeficiency Virus) infection. Patients with HIV can now survive well into old age. Aging with HIV has been associated with medical illness however neuropsychiatric symptoms including cognitive decline and behavioral dysregulation has been directly associated with aging and having HIV.
J AIDS HIV Treat, 2023, Volume 5, Issue 1, p9-12 | DOI: 10.33696/AIDS.5.041
Detection of Undiagnosed Elevated Cardiovascular Risk Biomarkers among HIV-Positive Patients on Antiretroviral Therapy (ART) in Kigali-City, Rwanda
Marcus Bushaku , Caleb Nyamwange , Arthur Kwena , Marc Twagirumukiza , Jean Nepo Utumatwishima , Regine Mugeni , Victor Davila-Roman , Aurore Nishimwe , Kenneth Schectman , W Todd Cade , Dominic Reeds , Eugene Mutimura
Similar to other African countries, life expectancy of people living with HIV infection has improved due to access to antiretroviral therapy (ART) in Rwanda. However, both HIV infection and use of ART are associated with cardiovascular disease (CVD) risks, due to adverse changes in some biomarkers, causing dyslipidemia and other metabolic imbalances. Biomarkers for CVD risk in HIV-infected individuals taking ART, has not been well characterized in Rwanda.
J AIDS HIV Treat, 2023, Volume 5, Issue 1 | DOI: 10.33696/AIDS.5.042
Death and Transferred Out as Competing Event for Lost to Follow-up among HIV-positive Adults on ART, in Eastern Ethiopia Governmental Hospitals from January 2015 to December 2021; (Multicenter Competing Risk Regression Analysis)
Girum Shibeshi Argaw , Kassahun Alemu Gelaye , Ayenew Molla Lakew , Yazachew Moges Chekol , Fantu Mamo Aragaw
Lost to follow-up (LTFU) among patients on antiretroviral therapy accounts for the most of all attrition. In Sub-Saharan Africa,there is a concern regarding high rates of LTFU and early mortality in antiretroviral therapy programs. Mortality and transferred out are the potential competing events for LTFU. Ignoring these events may give an invalid estimate by overestimating the probability of the occurrence of LTFU.
J AIDS HIV Treat, 2023, Volume 5, Issue 1, p22-33 | DOI: 10.33696/AIDS.5.043